Is Nephros Inc (NEPH) overvalued? · P/E 48, rev $14.2M
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
This page asks whether Nephros Inc (NEPH) looks expensive on cached numbers — not a short thesis.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
NEPH currently screens at market cap $40.9M and trailing P/E 48.3. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next NEPH 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the NEPH stock page for the full model, not this heading.
Not investment advice.